S 2443
114th Congress
Senate
Health
Cell biology and embryology
Drug safety, medical device, and laboratory regulation
Genetics
Medical research
Organ and tissue donation and transplantation
Public-private cooperation
Advancing Standards in Regenerative Medicine Act
Introduced: January 12, 2016
Introduced by:
Baldwin, Tammy
Democratic
· Wisconsin
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 12, 2016
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jan 12, 2016
Introduced in Senate
Plain-English summary
Advancing Standards in Regenerative Medicine Act
This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to facilitate the establishment of a public-private Standards Coordinating Body in Regenerative Medicine and Advanced Therapies. The FDA must work with this body to develop standards to support the development and review of regenerative medicine products.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committees of jurisdiction
1